Risk factors for checkpoint inhibitor pneumonitis in lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This meta-analysis identified 20 risk factors for checkpoint inhibitor pneumonitis (CIP) in lung cancer patients treated with immune checkpoint inhibitors (ICIs). Early identification of high-risk individuals is crucial for improving treatment safety and outcomes.
Area Of Science
- Oncology
- Pulmonology
- Immunology
Background
- Immune checkpoint inhibitors (ICIs) enhance survival in lung cancer.
- Checkpoint inhibitor pneumonitis (CIP) is a significant safety concern.
- Risk stratification is needed for optimal ICI management.
Purpose Of The Study
- To systematically evaluate demographic, clinical, and laboratory risk factors for CIP.
- To guide risk-stratified management of ICI-treated lung cancer patients.
- To improve the safety profile of immune checkpoint inhibitor therapy.
Main Methods
- Systematic literature search across eight databases.
- Quality assessment using Newcastle-Ottawa Scale (NOS).
- Meta-analysis of adjusted risk factors using RevMan 5.4.
Main Results
- 28 high-quality studies included, identifying 20 independent CIP risk factors.
- Key factors include advanced age, male sex, smoking, pre-existing lung conditions, specific cancer histology, metastatic burden, and certain ICI agents.
- Laboratory markers like elevated CRP, PLR, and hypoalbuminemia were also significant.
Conclusions
- Identified 20 independent risk factors for CIP in lung cancer patients receiving ICIs.
- Early screening and intervention for high-risk populations are essential.
- Findings offer actionable insights for optimizing ICI safety in clinical practice.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
• Pleurisy: indicates the inflammation of the pleura, which causes chest pain and discomfort.
• Pleural Effusion: indicates fluid buildup in the pleural space.
• Atelectasis: Partial collapse of a lung lobe due to mucus blockage or external compression.
• Bacteremia: Bacterial infection entering the bloodstream, commonly seen with...
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
• Chronic Cough: A persistent cough, often productive, is a crucial symptom of COPD.
•...
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The pathophysiology of pneumonia involves the following steps:
• Inhalation of Infectious Agents: Pneumonia typically begins when pathogenic organisms (bacteria, viruses, fungi) are inhaled or aspirated into the lower respiratory tract.
• Overcoming Lung Defenses: Ideally, the respiratory tract has defense mechanisms like mucociliary clearance and cough reflex to prevent the establishment of pathogenic organisms. If these defenses are compromised, or the pathogen is highly...
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....